Statins vs placebo or usual care
Rhabdomyolysis · Adults with chronic kidney disease not requiring dialysis
It is very uncertain whether statin therapy changes rhabdomyolysis compared with placebo or standard of care (very low certainty).
1 finding from 1 review
- HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis 2023 · Cochrane Headline outcomes onlyRR 3.07 [0.13, 75.37]2 studies · 2618 participantsVery low